Cleaning and Disinfection
Cleaning & Disinfection (C&D) Validation for Reusable Medical Devices
Shriram Institute for Industrial Research (SRI), Delhi, offers comprehensive Cleaning and Disinfection Validation Studies for Reusable Medical Devices in accordance with internationally recognized standards and regulatory expectations, including:
Regulatory Background
Reusable medical devices must be properly cleaned and disinfected between uses to ensure patient safety and prevent cross-contamination. Regulatory agencies require manufacturers to validate and document that:
- Cleaning procedures effectively remove soil, contaminants, and residues
- Disinfection processes consistently reduce microbial load to acceptable levels
- Instructions for Use (IFU) are scientifically validated and reproducible
The US FDA expects manufacturers to submit validated reprocessing instructions demonstrating safety and effectiveness under worst-case conditions.
Our Cleaning Validation Approach
At SRI Delhi, our cleaning validation studies are designed to simulate real-world clinical use and worst-case contamination scenarios.
Study Design Includes:
- Artificial soil preparation (blood, protein, organic contaminants)
- Worst-case contamination challenge
- Simulated-use testing cycles
- Manual cleaning process validation
- Residue analysis (protein, hemoglobin, TOC where applicable)
- Visual inspection and analytical quantification
We assess cleaning efficacy based on:
- Residual protein limits
- Organic carbon levels
- Microbial reduction benchmarks
- Surface cleanliness criteria
All protocols are designed in line with AAMI recommendations and FDA reprocessing guidance.
Disinfection Validation Studies
Disinfection validation ensures that the recommended process achieves effective microbial reduction.
Our Studies Cover:
- High-level disinfection validation
- Intermediate and low-level disinfection testing
- Log reduction studies for bacteria and fungi
- Time-kill and contact-time validation
- Compatibility assessment with device materials
Microbial challenge organisms are selected as per regulatory expectations to represent clinically relevant pathogens.
Key Regulatory Elements Addressed
Our validation studies address critical FDA and AAMI requirements such as:
- Worst-case scenario validation
- Repeated reprocessing cycle testing
- Validation of IFU cleaning instructions
- Compatibility of materials with cleaning agents
- Documentation suitable for regulatory submission
We generate comprehensive validation reports that can be included in 510(k), CE marking, or other regulatory submissions.
Why Cleaning & Disinfection Validation is Critical
Improper reprocessing of reusable medical devices may result in:
- Cross-infection risk
- Biofilm formation
- Residual contamination
- Regulatory non-compliance
- Product recall or warning letters
Robust validation ensures patient safety, regulatory compliance, and market acceptance.
Experience in conducting C&D studies
SRI Delhi successfully conducted more than +50 studies within a tenure of +10 Years for many National and Multinational companies for FDA Submission.